Avantor, Inc.

AVTR • Medical - Instruments & Supplies

$14.97

▼ -0.22 (-1.45%)

Current price

EarningsLatest report: Jun 30, 2026

HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.

Market Cap

$10.14B

Growth

23.3%

Cash Flow

5/5

Trend

Stable

Evidence

Positive free cash flow · 0.73Consistent free cash flow · 5/5Manageable debt level · 0.71Healthy liquidity · 1.78Negative growth trend

Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$14.97

Change-1.45%

Shares Out677.20M

Market Cap$10.14B

Enterprise Value$9.87B

52W Range7.26 - 15.93

Beta0.94

P/E-17.54

P/S1.55

P/B1.80

P/FCF35.15

EV/Sales1.50

Price$14.97

Change-1.45%

Shares Out677.20M

Market Cap$10.14B

Enterprise Value$9.87B

52W Range7.26 - 15.93

Beta0.94

P/E-17.54

P/S1.55

P/B1.80

P/FCF35.15

EV/Sales1.50

EV/EBITDA412.88

EV/FCF34.22

Earnings Yield-5.70%

FCF Yield2.84%

Dividend Yield0.00%

Gross Margin32.65%

Oper. Margin-3.76%

Profit Margin-8.09%

Debt/Eq0.71

Current Ratio1.78

Quick Ratio1.18

Revenue 5Y23.28%

FCF 5Y14.17%

Target$10.78

Target Upside-27.99%

Target Median$10.50

Target Range7.00 - 14.00

Volume15.36M

Avg Volume10.48M

EPS Surprise0.01

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

27/100

Financial Strength

Debt, cash, stability

66/100

Growth Potential

Revenue and expansion

20/100

Price Attractiveness

Cheap or expensive today

72/100

Why this score▼

Positive free cash flow · 0.73Consistent free cash flow · 5/5Manageable debt level · 0.71Healthy liquidity · 1.78Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

AVTR

Analyst sentiment

Based on 26 analyst votes · 2026-09-05

62/100

Neutral

Bullish

Hold

Bearish

Price Target

2026-07-31

Low

$7.00

Mean

$10.73

Median

$10.50

High

$14.00

Company Overview

IPO: 5/17/2019

Industry: Medical - Instruments & Supplies

P/B i: 1.80

Debt / Equity i: 0.71

Operating Margin: -3.76%

Net Margin: -8.09%

ROE i: -

ROIC: -

Financial Health

Score13 / 20

Debt / Equity: 0.71

Current Ratio: 1.78

Quick Ratio: 1.18

Status: Good

Insider Transactions

Recent executive and insider activity

Sokenu Claudius

Transaction: 07/24/2026

SELL

Change

-1,201

Price

$11.44

Filing

07/27/2026

Type

SELL

Walker Corey

Transaction: 06/21/2026

SELL

Change

-3,010

Price

$9.58

Filing

06/22/2026

Type

SELL

LUCIER GREGORY T

Transaction: 05/08/2026

BUY

Change

+10,000

Price

$8.32

Filing

05/11/2026

Type

BUY

Insider	Type	Change	Price	Transaction	Filing
Sokenu Claudius	SELL	-1,201	$11.44	07/24/2026	07/27/2026
Walker Corey	SELL	-3,010	$9.58	06/21/2026	06/22/2026
LUCIER GREGORY T	BUY	+10,000	$8.32	05/08/2026	05/11/2026
SUMME GREGORY L	BUY	+25,270	Not reported	05/07/2026	05/11/2026
SEVERINO MICHAEL	BUY	+25,270	Not reported	05/07/2026	05/11/2026
MEHRA SANJEEV K	BUY	+25,270	Not reported	05/07/2026	05/11/2026
Massaro Joseph R	BUY	+25,270	Not reported	05/07/2026	05/11/2026
Makin Louise	BUY	+25,270	Not reported	05/07/2026	05/11/2026
Dingemans Simon	BUY	+25,270	Not reported	05/07/2026	05/11/2026
LUCIER GREGORY T	BUY	+25,270	Not reported	05/07/2026	05/11/2026
Murthy Mala	BUY	+25,270	Not reported	05/07/2026	05/11/2026
Brellier Ludovic	OTHER	0	Not reported	05/01/2026	05/05/2026
Brellier Ludovic	BUY	+146,566	Not reported	05/01/2026	05/05/2026
Brellier Ludovic	BUY	+246,002	$8.76	05/01/2026	05/05/2026
Dingemans Simon	BUY	+25,000	$8.14	05/01/2026	05/05/2026
Eck Steven W	BUY	+31,645	Not reported	04/03/2026	04/06/2026
MEHRA SANJEEV K	BUY	+125,000	$8.01	03/10/2026	03/11/2026
Eck Steven W	SELL	-452	$9.11	02/24/2026	02/25/2026
Hankamer Brittany	SELL	-359	$9.11	02/24/2026	02/25/2026
Eck Steven W	SELL	-2,017	$8.89	02/23/2026	02/25/2026

About the Company

Avantor, Inc.

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.

Source - link

Peers

ATR BAX BIO GRFS HSIC MASI MOH RGEN STVN

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?

Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.

Zacks Investment Research

Why Is Avantor (AVTR) Up 5.4% Since Last Earnings Report?

Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research

Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?

AVTR's Revival Program is lifting VWR growth and BMP orders, but margin pressure and soft earnings keep the recovery selective despite a higher 2026 outlook.

Zacks Investment Research

Callan Family Office LLC Invests $2.02 Million in Avantor, Inc. $AVTR

Callan Family Office LLC acquired a new position in Avantor, Inc. (NYSE: AVTR) during the quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 204,134 shares of the company's stock, valued at approximately $2,021,000. Several other hedge funds and other

Defense World

Advisors Capital Management LLC Invests $4.37 Million in Avantor, Inc. $AVTR

Advisors Capital Management LLC purchased a new position in shares of Avantor, Inc. (NYSE: AVTR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 441,317 shares of the company's stock, valued at approximately $4,369,000. Advisors Capital Management LLC owned about 0.07% of

Defense World

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-04-29	0.16	0.17	0.01
2026-02-11	0.21	0.22	0.01
2025-10-29	0.2248	0.22	-0.0048
2025-08-01	0.25	0.24	-0.01
2025-04-25	0.2314	0.23	-0.0014
2025-02-07	0.25	0.27	0.02
2024-10-25	0.2546	0.26	0.0054
2024-07-26	0.2324	0.25	0.0176
2024-04-26	0.201	0.22	0.019
2024-02-14	0.22	0.25	0.03
2023-10-27	0.25	0.25	0
2023-07-28	0.29	0.28	-0.01